Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration

Tumor growth is dependent both on endothelial and tumor cells. The aim of this study was to investigate dynamically whether changes in tumor vasculature implicate tumor tissue degeneration during antiangiogenic therapies. In order to quantify intra-tumor vascularization and necrosis, we have used ultrasound technology. This study has identified essential parameters needed to quantify specifically and sensitively the number of microvessels and the extent of necrosis in xenografted human carcinomas during natural tumor evolution, using contrast-enhanced high-frequency ultrasonography with (HFCDUS) or without (HFUS) color Doppler. We showed that quantification of intra-tumor microvessels between HFCDUS and immunohistochemistry is correlated using an anti-CD31 antibody. Furthermore, quantification of tumor necrosis with HFUS was confirmed by histological examination of hematoxylin–eosin–saffranin-stained sections over the observation period. Subsequently, for the assessment of novel angiogenic inhibitors, HFCDUS and HFUS were used to elucidate the underlying dynamics linking vessel inhibition and tumor eradication. We describe a novel application for HFCDUS/HFUS that constitutes an effective, convenient, and non-invasive method for clinical assessment of angiogenic inhibitors. In conclusion, we showed that tumor cells abruptly became necrotic following an antivascular therapy, whereas untreated tumors were protected from degeneration by a significant blood supply.

[1]  T. Yahata,et al.  Primary choriocarcinoma of the uterine cervix: clinical, MRI, and color Doppler ultrasonographic study. , 1997, Gynecologic oncology.

[2]  P. Opolon,et al.  Canstatin Acts on Endothelial and Tumor Cells via Mitochondrial Damage Initiated through Interaction with αvβ3 and αvβ5 Integrins , 2005 .

[3]  F. Hsieh,et al.  Comparison between `in vivo' and `in vitro' methods for evaluating tumor angiogenesis using cervical carcinoma as a model , 2004, Angiogenesis.

[4]  Nathalie Lassau,et al.  Validation of a New Method for Quantifying In Vivo Murine Tumor Necrosis by Sonography , 2004, Investigative radiology.

[5]  M. Tozaki,et al.  Power Doppler sonography of breast masses: correlation of Doppler spectral parameters with tumor angiogenesis and histologic growth pattern. , 2000, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[6]  W. Hatzmann,et al.  Does texture analysis improve breast ultrasound precision? , 2000, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[7]  W. Beecken,et al.  Sonographic evaluation of orthotopic bladder tumors in mice treated with TNP-470, an angiogenic inhibitor. , 2001, Academic radiology.

[8]  M. Helvie,et al.  Small (< 2.0-cm) breast cancers: mammographic and US findings at US-guided cryoablation--initial experience. , 2004, Radiology.

[9]  A. Lee,et al.  Microvessel quantitation and prognosis in invasive breast carcinoma. , 1992, Human pathology.

[10]  A. Harris,et al.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer , 1992, The Lancet.

[11]  F. Mami-Chouaib,et al.  Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography , 1999, Gene Therapy.

[12]  M. Christian,et al.  [New guidelines to evaluate the response to treatment in solid tumors]. , 2000, Bulletin du cancer.

[13]  P. Opolon,et al.  Evaluation of Contrast-Enhanced Color Doppler Ultrasound for the Quantification of Angiogenesis In Vivo , 2001, Investigative radiology.

[14]  A. Stavros,et al.  Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. , 1995, Radiology.

[15]  B. Zetter,et al.  Tumor vascularity: evaluation in a murine model with contrast-enhanced color Doppler US effect of angiogenesis inhibitors. , 2002, Radiology.

[16]  K. Mandai,et al.  Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma , 2004, Cancer Chemotherapy and Pharmacology.

[17]  P. Hahnfeldt,et al.  Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. , 2002, Journal of the National Cancer Institute.

[18]  J. Berlin,et al.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.

[19]  P. Forestieri,et al.  Solitary necrotic nodule of the liver misinterpreted as malignant lesion: Considerations on two cases , 2000, Journal of surgical oncology.

[20]  M. Toi,et al.  Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma , 1993, International journal of cancer.

[21]  Patrick Nicolas,et al.  Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. , 2004, Cancer research.

[22]  F. Stuart Foster,et al.  High-frequency color flow imaging of the microcirculation , 2000 .

[23]  J. Folkman,et al.  Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice. , 2000, Urology.

[24]  D R Pickens,et al.  Quantified color Doppler sonography of tumor vascularity in an animal model. , 1999, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[25]  O. Papakonstantinou,et al.  High-resolution and color doppler ultrasonography of cervical lymphadenopathy in children , 2001 .

[26]  S M Evans,et al.  Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. , 2001, Cancer research.

[27]  P. Opolon,et al.  Full kringles of plasminogen (aa 1–566) mediate complete regression of human MDA-MB-231 breast tumor xenografted in nude mice , 2005, Gene Therapy.

[28]  Correlation of Doppler US Tumor Signals with Neovascular Morphologic Features , 1988 .

[29]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[30]  Barbara Mayer,et al.  Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  Dallas M. Hyde,et al.  A Guide to Practical Stereology , 1983 .

[32]  F Forsberg,et al.  Clinical applications of ultrasound contrast agents. , 1998, Ultrasonics.

[33]  Fabian Kiessling,et al.  Sensitive noninvasive monitoring of tumor perfusion during antiangiogenic therapy by intermittent bolus-contrast power Doppler sonography. , 2003, Cancer research.

[34]  N. Miyokawa,et al.  Differentiation between benign and metastatic cervical lymph nodes with ultrasound. , 1997, Clinical radiology.

[35]  Nobuo Okuyama,et al.  The use of Doppler ultrasound in evaluation of breast cancer metastasis to axillary lymph nodes. , 2004, Oncology reports.

[36]  P. Choyke,et al.  Imaging of angiogenesis: from microscope to clinic , 2003, Nature Medicine.

[37]  V. R. McCready,et al.  Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. , 1996, Radiology.

[38]  David Opolon,et al.  Combined effects of docetaxel and angiostatin gene therapy in prostate tumor model. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[39]  V. Brower.  Evidence of efficacy: researchers investigating markers for angiogenesis inhibitors. , 2003, Journal of the National Cancer Institute.

[40]  Wei Tse Yang,et al.  Correlation Between Color Power Doppler Sonographic Measurement of Breast Tumor Vasculature and Immunohistochemical Analysis of Microvessel Density for the Quantitation of Angiogenesis , 2002, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[41]  J. Folkman,et al.  Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors , 1972, Annals of surgery.

[42]  D. Chen,et al.  Computer-aided diagnosis applied to US of solid breast nodules by using neural networks. , 1999, Radiology.

[43]  G. Bartsch,et al.  Contrast-enhanced transrectal color doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer. , 2001, Anticancer research.

[44]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[45]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[46]  F. Calliada,et al.  Ultrasound contrast agents: basic principles. , 1998, European journal of radiology.

[47]  P. Hauff,et al.  Tumor vascularization in experimental melanomas: correlation between unenhanced and contrast enhanced power Doppler imaging and histological grading. , 2001, Ultrasound in medicine & biology.